{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "chronic kidney disease", "inflammation", "nootkatone", "renal fibrosis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34836176", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "07"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "01"}], "Language": ["eng"], "ELocationID": ["3921", "10.3390/nu13113921"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "13", "Issue": "11", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "01"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Protective Effects of Nootkatone on Renal Inflammation, Apoptosis, and Fibrosis in a Unilateral Ureteral Obstructive Mouse Model.", "Abstract": {"AbstractText": ["Nootkatone is one of the major active ingredients of <i>Alpiniae oxyphyllae</i>, which has been used as both food and medicinal plants for the treatment of diarrhea, ulceration, and enuresis. In this study, we aimed to investigate whether nootkatone treatment ameliorated the progression of chronic kidney diseases (CKD) and clarified its underlying mechanisms in an obstructive nephropathy (unilateral ureteral obstructive; UUO) mouse model. Our results revealed that nootkatone treatment preventively decreased the pathological changes and significantly mitigated the collagen deposition as well as the protein expression of fibrotic markers. Nootkatone could also alleviate oxidative stress-induced injury, inflammatory cell infiltration, and renal cell apoptotic death in the kidneys of UUO mice. These results demonstrated for the first time that nootkatone protected against the progression of CKD in a UUO mouse model. It may serve as a potential therapeutic candidate for CKD intervention."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Neurosurgery, Department of Surgery, College of Medicine and Hospital, National Taiwan University, Taipei 10051, Taiwan."}], "LastName": "Chen", "ForeName": "Chang-Mu", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan."}], "LastName": "Lin", "ForeName": "Chen-Yu", "Initials": "CY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan."}], "LastName": "Chung", "ForeName": "Yao-Pang", "Initials": "YP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11041, Taiwan."}, {"Identifier": [], "Affiliation": "TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 11041, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan."}], "LastName": "Liu", "ForeName": "Chia-Hung", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 10051, Taiwan."}], "LastName": "Huang", "ForeName": "Kuo-Tong", "Initials": "KT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan 32546, Taiwan."}], "LastName": "Guan", "ForeName": "Siao-Syun", "Initials": "SS"}, {"Identifier": ["0000-0002-7240-8465"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, China Medical University, Taichung 406040, Taiwan."}, {"Identifier": [], "Affiliation": "Master Program of Food and Drug Safety, China Medical University, Taichung 406040, Taiwan."}], "LastName": "Wu", "ForeName": "Cheng-Tien", "Initials": "CT"}, {"Identifier": ["0000-0002-9976-1197"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 406040, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Paediatrics, National Taiwan University Hospital, Taipei 10051, Taiwan."}], "LastName": "Liu", "ForeName": "Shing-Hwa", "Initials": "SH"}], "GrantList": [{"GrantID": "MOST 109-2314-B-039-043-MY3", "Agency": "Ministry of Science and Technology of Taiwan", "Country": ""}, {"GrantID": "CMU109-N-13", "Agency": "China Medical University, Taiwan", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Sesquiterpenes"}, {"RegistryNumber": "IZ2Y119N4J", "NameOfSubstance": "nootkatone"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Alpinia"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Fibrosis"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Polycyclic Sesquiterpenes"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Renal Insufficiency, Chronic"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Carney E.F. The impact of chronic kidney disease on global health. Nat. Rev. Nephrol. 2020;16:251. doi: 10.1038/s41581-020-0268-7.", "ArticleIdList": ["10.1038/s41581-020-0268-7", "32144399"]}, {"Citation": "Nogueira A., Pires M.J., Oliveira P.A. Pathophysiological mechanisms of renal fibrosis: A review of animal models and therapeutic strategies. In Vivo. 2017;31:1\u201322. doi: 10.21873/invivo.11019.", "ArticleIdList": ["10.21873/invivo.11019", "PMC5354133", "28064215"]}, {"Citation": "Grande M.T., Lopez-Novoa J.M. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol. 2009;5:319\u2013328. doi: 10.1038/nrneph.2009.74.", "ArticleIdList": ["10.1038/nrneph.2009.74", "19474827"]}, {"Citation": "Sean Eardley K., Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int. 2005;68:437\u2013455. doi: 10.1111/j.1523-1755.2005.00422.x.", "ArticleIdList": ["10.1111/j.1523-1755.2005.00422.x", "16014021"]}, {"Citation": "Tammaro A., Stroo I., Rampanelli E., Blank F., Butter L.M., Claessen N., Takai T., Colonna M., Leemans J.C., Florquin S., et al. Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy. PLoS ONE. 2013;8:e82498. doi: 10.1371/journal.pone.0082498.", "ArticleIdList": ["10.1371/journal.pone.0082498", "PMC3864959", "24358193"]}, {"Citation": "Liu F., Zhuang S. New therapies for the treatment of renal fibrosis. Adv. Exp. Med. Biol. 2019;1165:625\u2013659. doi: 10.1007/978-981-13-8871-2_31.", "ArticleIdList": ["10.1007/978-981-13-8871-2_31", "31399988"]}, {"Citation": "Zhang Q., Zheng Y., Hu X., Lv W., Lv D., Chen J., Wu M., Song Q., Shentu J. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel: A review. J. Ethnopharmacol. 2018;224:149\u2013168. doi: 10.1016/j.jep.2018.05.002.", "ArticleIdList": ["10.1016/j.jep.2018.05.002", "29738847"]}, {"Citation": "Lee Y.S., Sung Y.Y., Yuk H.J., Son E., Lee S., Kim J.S., Kim D.S. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney. Phytomedicine. 2019;62:152975. doi: 10.1016/j.phymed.2019.152975.", "ArticleIdList": ["10.1016/j.phymed.2019.152975", "31181404"]}, {"Citation": "Zhang Q., Hu X., Hui F., Song Q., Cui C., Wang C., Zhao Q. Ethanol extract and its dichloromethane fraction of Alpinia oxyphylla Miquel exhibited hepatoprotective effects against CCl4-induced oxidative damage in vitro and in vivo with the involvement of Nrf2. Biomed. Pharmacother. 2017;91:812\u2013822. doi: 10.1016/j.biopha.2017.04.131.", "ArticleIdList": ["10.1016/j.biopha.2017.04.131", "28501008"]}, {"Citation": "Du G., Xiao M., Zhang X., Wen M., Pang C., Jiang S., Sang S., Xie Y. Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney. Biol. Res. 2017;50:9. doi: 10.1186/s40659-017-0111-1.", "ArticleIdList": ["10.1186/s40659-017-0111-1", "PMC5331689", "28249617"]}, {"Citation": "Qi Y., Cheng X., Gong G., Yan T., Du Y., Wu B., Bi K., Jia Y. Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway. Food Funct. 2020;11:2427\u20132438. doi: 10.1039/C9FO02927C.", "ArticleIdList": ["10.1039/C9FO02927C", "32129354"]}, {"Citation": "Kurdi A., Hassan K., Venkataraman B., Rajesh M. Nootkatone confers hepatoprotective and anti-fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis. J. Biochem. Mol. Toxicol. 2018;32:10\u20131002. doi: 10.1002/jbt.22017.", "ArticleIdList": ["10.1002/jbt.22017", "29214688"]}, {"Citation": "Chevalier R.L., Forbes M.S., Thornhill B.A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75:1145\u20131152. doi: 10.1038/ki.2009.86.", "ArticleIdList": ["10.1038/ki.2009.86", "19340094"]}, {"Citation": "Eddy A.A., Lopez-Guisa J.M., Okamura D.M., Yamaguchi I. Investigating mechanisms of chronic kidney disease in mouse models. Pediatr. Nephrol. 2012;27:1233\u20131247. doi: 10.1007/s00467-011-1938-2.", "ArticleIdList": ["10.1007/s00467-011-1938-2", "PMC3199379", "21695449"]}, {"Citation": "Chen H.A., Chen C.M., Guan S.S., Chiang C.K., Wu C.T., Liu S.H. The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model. Phytomedicine. 2019;59:152917. doi: 10.1016/j.phymed.2019.152917.", "ArticleIdList": ["10.1016/j.phymed.2019.152917", "30978648"]}, {"Citation": "Wu C.T., Sheu M.L., Tsai K.S., Chiang C.K., Liu S.H. Salubrinal, an eIF2\u03b1 dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. Free Radic. Biol. Med. 2011;51:671\u2013680. doi: 10.1016/j.freeradbiomed.2011.04.038.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.04.038", "21616140"]}, {"Citation": "Chen C.M., Chung Y.P., Liu C.H., Huang K.T., Guan S.S., Chiang C.K., Wu C.T., Liu S.H. Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction. Phytomedicine. 2020;79:153352. doi: 10.1016/j.phymed.2020.153352.", "ArticleIdList": ["10.1016/j.phymed.2020.153352", "33007732"]}, {"Citation": "Chen C.M., Wu C.T., Yang T.H., Chang Y.A., Sheu M.L., Liu S.H. Green tea catechin prevents hypoxia/reperfusion-evoked oxidative stress-regulated autophagy-activated apoptosis and cell death in microglial cells. J. Agric. Food Chem. 2016;64:4078\u20134085. doi: 10.1021/acs.jafc.6b01513.", "ArticleIdList": ["10.1021/acs.jafc.6b01513", "27144449"]}, {"Citation": "Moriyama T., Kawada N., Akagi Y., Ando A., Horio M., Yamauchi A., Nagata K., Imai E., Hori M. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy. Kidney Int. Suppl. 1997;63:S232\u2013S235.", "ArticleIdList": ["9407468"]}, {"Citation": "Chiang C.K., Hsu S.P., Wu C.T., Huang J.W., Cheng H.T., Chang Y.W., Hung K.Y., Wu K.D., Liu S.H. Endoplasmic reticulum stress implicated in the development of renal fibrosis. Mol. Med. 2011;17:1295\u20131305. doi: 10.2119/molmed.2011.00131.", "ArticleIdList": ["10.2119/molmed.2011.00131", "PMC3324175", "21863214"]}, {"Citation": "Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 2010;21:212\u2013222. doi: 10.1681/ASN.2008121226.", "ArticleIdList": ["10.1681/ASN.2008121226", "PMC4554339", "20019167"]}, {"Citation": "Yin Q., Liu H. Connective tissue growth factor and renal fibrosis. Adv. Exp. Med. Biol. 2019;1165:365\u2013380. doi: 10.1007/978-981-13-8871-2_17.", "ArticleIdList": ["10.1007/978-981-13-8871-2_17", "31399974"]}, {"Citation": "Badid C., Desmouliere A., Babici D., Hadj-Aissa A., McGregor B., Lefrancois N., Touraine J.L., Laville M. Interstitial expression of alpha-SMA: An early marker of chronic renal allograft dysfunction. Nephrol. Dial. Transplant. 2002;17:1993\u20131998. doi: 10.1093/ndt/17.11.1993.", "ArticleIdList": ["10.1093/ndt/17.11.1993", "12401859"]}, {"Citation": "Dendooven A., Ishola D.A., Jr., Nguyen T.Q., Van der Giezen D.M., Kok R.J., Goldschmeding R., Joles J.A. Oxidative stress in obstructive nephropathy. Int. J. Exp. Pathol. 2011;92:202\u2013210. doi: 10.1111/j.1365-2613.2010.00730.x.", "ArticleIdList": ["10.1111/j.1365-2613.2010.00730.x", "PMC3101492", "20804541"]}, {"Citation": "Su H., Wan C., Song A., Qiu Y., Xiong W., Zhang C. Oxidative stress and renal fibrosis: Mechanisms and therapies. Adv. Exp. Med. Biol. 2019;1165:585\u2013604. doi: 10.1007/978-981-13-8871-2_29.", "ArticleIdList": ["10.1007/978-981-13-8871-2_29", "31399986"]}, {"Citation": "Cheng X., Zheng X., Song Y., Qu L., Tang J., Meng L., Wang Y. Apocynin attenuates renal fibrosis via inhibition of NOXs-ROS-ERK-myofibroblast accumulation in UUO rats. Free Radic. Res. 2016;50:840\u2013852. doi: 10.1080/10715762.2016.1181757.", "ArticleIdList": ["10.1080/10715762.2016.1181757", "27109518"]}, {"Citation": "Yan T., Li F., Xiong W., Wu B., Xiao F., He B., Jia Y. Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury. Environ. Toxicol. 2021;36:694\u2013706. doi: 10.1002/tox.23073.", "ArticleIdList": ["10.1002/tox.23073", "33270352"]}, {"Citation": "Meeran M.F.N., Azimullah S., Adeghate E., Ojha S. Nootkatone attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats. Phytomedicine. 2021;84:153405. doi: 10.1016/j.phymed.2020.153405.", "ArticleIdList": ["10.1016/j.phymed.2020.153405", "33636578"]}, {"Citation": "Bondi C.D., Manickam N., Lee D.Y., Block K., Gorin Y., Abboud H.E., Barnes J.L. NAD(P)H oxidase mediates TGF-\u03b21-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 2010;21:93\u2013102. doi: 10.1681/ASN.2009020146.", "ArticleIdList": ["10.1681/ASN.2009020146", "PMC2799274", "19926889"]}, {"Citation": "Oldroyd S.D., Huang L.H., Yang B., Zhang G., Li Y., Ye R., El Nahas A.M. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Exp. Nephrol. 2001;9:71\u201380. doi: 10.1159/000052597.", "ArticleIdList": ["10.1159/000052597", "11150855"]}, {"Citation": "Jang H.S., Padanilam B.J. Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy. Am. J. Physiol. Renal Physiol. 2015;309:F540\u2013F550. doi: 10.1152/ajprenal.00170.2015.", "ArticleIdList": ["10.1152/ajprenal.00170.2015", "PMC4572396", "26180237"]}, {"Citation": "Nemmar A., Al-Salam S., Beegam S., Yuvaraju P., Hamadi N., Ali B.H. In vivo protective effects of nootkatone against particles-induced lung injury caused by diesel exhaust is mediated via the NF-\u03baB pathway. Nutrients. 2018;10:263. doi: 10.3390/nu10030263.", "ArticleIdList": ["10.3390/nu10030263", "PMC5872681", "29495362"]}, {"Citation": "Martinez-Klimova E., Aparicio-Trejo O.E., Tapia E., Pedraza-Chaverri J. Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules. 2019;9:141. doi: 10.3390/biom9040141.", "ArticleIdList": ["10.3390/biom9040141", "PMC6523883", "30965656"]}, {"Citation": "Chavez-Iniguez J.S., Navarro-Gallardo G.J., Medina-Gonzalez R., Alcantar-Vallin L., Garcia-Garcia G. Acute kidney injury caused by obstructive nephropathy. Int. J. Nephrol. 2020;2020:8846622. doi: 10.1155/2020/8846622.", "ArticleIdList": ["10.1155/2020/8846622", "PMC7719507", "33312728"]}, {"Citation": "Akposso K., Hertig A., Couprie R., Flahaut A., Alberti C., Karras G.A., Haymann J.P., Costa De Beauregard M.A., Lahlou A., Rondeau E., et al. Acute renal failure in patients over 80 years old: 25-years\u2019 experience. Intensive Care Med. 2000;26:400\u2013406. doi: 10.1007/s001340051173.", "ArticleIdList": ["10.1007/s001340051173", "10872131"]}, {"Citation": "Rule A.D., Krambeck A.E., Lieske J.C. Chronic kidney disease in kidney stone formers. Clin. J. Am. Soc. Nephrol. 2011;6:2069\u20132075. doi: 10.2215/CJN.10651110.", "ArticleIdList": ["10.2215/CJN.10651110", "PMC3156433", "21784825"]}, {"Citation": "Hippisley-Cox J., Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: Prospective derivation and external validation of the QKidney Scores. BMC Fam. Pract. 2010;11:49. doi: 10.1186/1471-2296-11-49.", "ArticleIdList": ["10.1186/1471-2296-11-49", "PMC2905345", "20565929"]}, {"Citation": "Stankus N., Hammes M., Gillen D., Worcester E. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol. Res. 2007;35:83\u201387. doi: 10.1007/s00240-007-0079-3.", "ArticleIdList": ["10.1007/s00240-007-0079-3", "17310350"]}, {"Citation": "Farris A.B., Alpers C.E. What is the best way to measure renal fibrosis? A pathologist\u2019s perspective. Kidney Int. Suppl. 2014;4:9\u201315. doi: 10.1038/kisup.2014.3.", "ArticleIdList": ["10.1038/kisup.2014.3", "PMC4536972", "26312144"]}, {"Citation": "Menn-Josephy H., Lee C.S., Nolin A., Christov M., Rybin D.V., Weinberg J.M., Henderson J., Bonegio R., Havasi A. Renal interstitial fibrosis: An imperfect predictor of kidney disease progression in some patient cohorts. Am. J. Nephrol. 2016;44:289\u2013299. doi: 10.1159/000449511.", "ArticleIdList": ["10.1159/000449511", "PMC5069171", "27626625"]}, {"Citation": "Chen L., Yang T., Lu D.W., Zhao H., Feng Y.L., Chen H., Chen D.Q., Vaziri N.D., Zhao Y.Y. Central role of dysregulation of TGF-\u03b2/Smad in CKD progression and potential targets of its treatment. Biomed. Pharmacother. 2018;101:670\u2013681. doi: 10.1016/j.biopha.2018.02.090.", "ArticleIdList": ["10.1016/j.biopha.2018.02.090", "29518614"]}, {"Citation": "Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 1992;20:1\u201317. doi: 10.1016/S0272-6386(12)80312-X.", "ArticleIdList": ["10.1016/S0272-6386(12)80312-X", "1621674"]}, {"Citation": "Rodriguez-Iturbe B., Johnson R.J., Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int. Suppl. 2005;99:S82\u2013S86. doi: 10.1111/j.1523-1755.2005.09915.x.", "ArticleIdList": ["10.1111/j.1523-1755.2005.09915.x", "16336583"]}, {"Citation": "Higashi K., Oda T., Kushiyama T., Hyodo T., Yamada M., Suzuki S., Sakurai Y., Miura S., Kumagai H. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice. Nephrology. 2010;15:327\u2013335. doi: 10.1111/j.1440-1797.2009.01253.x.", "ArticleIdList": ["10.1111/j.1440-1797.2009.01253.x", "20470302"]}, {"Citation": "Kumagai H., Sakata K., Matsuura T., Imai M., Onami T., Iigaya K., Saruta T. Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis. Nihon Rinsho. 2002;60:2005\u20132013.", "ArticleIdList": ["12397699"]}, {"Citation": "Hu Y.H., Liu J., Li H., Tang W., Li X.W., Guo Y.W. Chemical constituents from citrus changshan-huyou and their anti-inflammatory activities. Chem. Biodivers. 2020;17:e2000503. doi: 10.1002/cbdv.202000503.", "ArticleIdList": ["10.1002/cbdv.202000503", "32940397"]}, {"Citation": "Xie J., Wang S., Sun B., Ito Y. Isolation and purification of nootkatone from the essential oil of fruits of Alpinia oxyphylla Miquel by high-speed counter-current chromatography. Food Chem. 2009;117:375\u2013380. doi: 10.1016/j.foodchem.2009.04.011.", "ArticleIdList": ["10.1016/j.foodchem.2009.04.011", "PMC2832474", "20209043"]}, {"Citation": "Miao Q., Kong W., Zhao X., Yang S., Yang M. GC-FID coupled with chemometrics for quantitative and chemical fingerprinting analysis of Alpinia oxyphylla oil. J. Pharm. Biomed. Anal. 2015;102:436\u2013442. doi: 10.1016/j.jpba.2014.10.014.", "ArticleIdList": ["10.1016/j.jpba.2014.10.014", "25459943"]}, {"Citation": "Xie Y., Xiao M., Li D., Liu H., Yun F., Wei Y., Sang S., Du G. Anti-diabetic effect of Alpinia oxyphylla extract on 57BL/KsJ db-/db- mice. Exp. Ther. Med. 2017;13:1321\u20131328. doi: 10.3892/etm.2017.4152.", "ArticleIdList": ["10.3892/etm.2017.4152", "PMC5377374", "28413472"]}, {"Citation": "Wang Y., Wang M., Xu M., Li T., Fan K., Yan T., Xiao F., Bi K., Jia Y. Nootkatone, a neuroprotective agent from Alpiniae oxyphyllae fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer\u2019s disease. Int. Immunopharmacol. 2018;62:77\u201385. doi: 10.1016/j.intimp.2018.06.042.", "ArticleIdList": ["10.1016/j.intimp.2018.06.042", "29990697"]}, {"Citation": "Li J., Du Q., Li N., Du S., Sun Z. Alpiniae oxyphyllae Fructus and Alzheimer\u2019s disease: An update and current perspective on this traditional Chinese medicine. Biomed. Pharmacother. 2021;135:111167. doi: 10.1016/j.biopha.2020.111167.", "ArticleIdList": ["10.1016/j.biopha.2020.111167", "33383373"]}, {"Citation": "Meeran M.F.N., Azimullah S., Al Ahbabi M.M., Jha N.K., Lakshmanan V.K., Goyal S.N., Ojha S. Nootkatone, a dietary fragrant bioactive compound, attenuates dyslipidemia and intramyocardial lipid accumulation and favorably alters lipid metabolism in a rat model of myocardial injury: An in vivo and in vitro study. Molecules. 2020;25:5656. doi: 10.3390/molecules25235656.", "ArticleIdList": ["10.3390/molecules25235656", "PMC7730250", "33266249"]}, {"Citation": "Bezerra Rodrigues Dantas L., Silva A.L.M., da Silva Junior C.P., Alcantara I.S., Correia de Oliveira M.R., Oliveira Brito Pereira Bezerra Martins A., Ribeiro-Filho J., Coutinho H., Rocha Santos Passos F., Quintans-Junior L.J., et al. Nootkatone inhibits acute and chronic inflammatory responses in mice. Molecules. 2020;25:2181. doi: 10.3390/molecules25092181.", "ArticleIdList": ["10.3390/molecules25092181", "PMC7248960", "32392744"]}, {"Citation": "Ucero A.C., Benito-Martin A., Izquierdo M.C., Sanchez-Nino M.D., Sanz A.B., Ramos A.M., Berzal S., Ruiz-Ortega M., Egido J., Ortiz A. Unilateral ureteral obstruction: Beyond obstruction. Int. Urol. Nephrol. 2014;46:765\u2013776. doi: 10.1007/s11255-013-0520-1.", "ArticleIdList": ["10.1007/s11255-013-0520-1", "24072452"]}, {"Citation": "Chevalier R.L. Chronic partial ureteral obstruction and the developing kidney. Pediatr. Radiol. 2008;38((Suppl. S1)):S35\u2013S40. doi: 10.1007/s00247-007-0585-z.", "ArticleIdList": ["10.1007/s00247-007-0585-z", "18071697"]}, {"Citation": "Kakimoto M., Inoguchi T., Sonta T., Yu H.Y., Imamura M., Etoh T., Hashimoto T., Nawata H. Accumulation of 8-hydroxy-2\u2019-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 2002;51:1588\u20131595. doi: 10.2337/diabetes.51.5.1588.", "ArticleIdList": ["10.2337/diabetes.51.5.1588", "11978660"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "17"}, {"Year": "2021", "Month": "10", "Day": "28"}, {"Year": "2021", "Month": "10", "Day": "29"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "29"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34836176", "PMC8621682", "10.3390/nu13113921", "nu13113921"]}}], "PubmedBookArticle": []}